spacer
home > > summer 2002 > change management through the looking glass
PUBLICATIONS


Change Management Through the Looking Glass

Beyond the world of comfortable consistency lies a wonderland of chaotic uncertainty - the domain of change. The journey down the rabbit hole to the unknown often begins as a peek into tiny management and process doorways through which we want to squeeze painlessly into a beautiful garden of transformation. Change is never easy. Lewis Carroll's Alice in Wonderland began navigating change by questioning her very name and then swimming in a pool of her own tears. Dealing with change is no less demanding in the pharmaceutical industry. Competitive stakes are high and getting higher. The first company to market with a blockbuster drug can enjoy a virtual monopoly for years and possibly transform the lives of millions of people. Accepting the inevitability of change is a start. However, it is those who harness and manage the power of change that can sustain the momentum of competitive advantage.

Change and adaptation within the clinical trial process - particularly through effective automation - can make a tremendous difference to business throughput. Over time, the clinical trial process has evolved into an administrative hierarchy. People with years of experience in this context implement various common methodologies accepted for their apparent reliability. But the pressure of competition has no respect for hierarchy. Commonly accepted practices are rarely an adequate basis for breakthrough competitive results. Many of the delays in the drug development process are largely a consequence of slow adaptation to the pressures of competitive change.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Philip Holt, Vice President of Life Sciences at Integic Corporation

Philip Holt is Vice President of Life Sciences at Integic Corporation. He has worked extensively over the past two decades in the development of technology strategies and methodologies oriented toward repeatable results.

Philip has also held management and executive positions at Baxter, Oacis Healthcare Systems and SAIC, as well as founding Altis, an international consultancy.

spacer
Philip Holt
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

High Throughput Analytics Herald a Paradigm Shift in the Development of Biopharmaceuticals

Heilbronn/Dortmund August 2019: Biopharmaceuticals have revolutionized therapies of various diseases. In particular with regard to chronical and/or severe clinical conditions like multiple sclerosis, rheumatoid arthritis or cancer they are considered the future of treatment. Also economically biological drugs are on their way up: The global biopharmaceuticals market is anticipated to reach about 400 billion USD by 2025. Which strategic alignment will help best to fill a successful pipeline?
More info >>

White Papers

Challenges of Analytical Method Transfer in the Pharmaceutical Industry

RSSL

The development and validation of suitable analytical methods is a critical part of the overall drug-development life-cycle. For the majority of products, particularly those that are clinically successful, the transfer of the analytical method between laboratories will be required. This process is designed to verify that a given laboratory is capable of performing a test method for its intended purpose. This can be performed either internally (at the same company), or, with the on-going increasing trend in outsourcing, to an external Contract Research or Development organisation (CRO or CDO).
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement